Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 138   

Articles published

GSK 1,462.31 +3.31 (0.23%)
price chart
Better buy: GlaxoSmithKline plc vs Shire plc
On the face of it, GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are both very similar; large, globe-spanning pharmaceutical companies with cutting-edge treatments for a range of diseases.
GlaxoSmithKline plc's (GSK) Buy Rating Reiterated at Goldman Sachs Group Inc.
GlaxoSmithKline plc logo Goldman Sachs Group Inc. reissued their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Thursday morning.
GlaxoSmithKline PLC (NYSE:GSK) will report its next earnings on Feb 1 - Feb ...  The Newburgh Press
Today, The Investment Analysts' Recent Ratings Updates for ...  DailyQuint
GlaxoSmithKline PLC (GSK) Rating Reiterated by Goldman Sachs Group Inc.
GlaxoSmithKline PLC logo GlaxoSmithKline PLC (NYSE:GSK)'s stock had its “buy” rating reiterated by Goldman Sachs Group Inc. in a research note issued on Thursday.
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by JPMorgan Chase & Co.  Sports Perspectives
Important Rating: Professional Analysts at JP Morgan Cazenove Didn't ...  Thorold News
Stocks to Keep Your Eyes on: GlaxoSmithKline plc (NYSE:GSK), QEP Resources ...
The consensus recommendation for GlaxoSmithKline plc (NYSE:GSK) is 1.86. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold.
Market Fallers: Fresnillo Plc, GKN plc, Glencore PLC, GlaxoSmithKline plc
The share price for Fresnillo Plc company symbol: LON:FRES has declined -4.17% or -50 points during today's session so far.
GlaxoSmithKline plc (GSK) Given "Buy" Rating at Goldman Sachs ...  Community Financial News
Today: GlaxoSmithKline plc (GSK) PT Raised to GBX 1950 at Jefferies Group  DailyQuint
Form 6-K GLAXOSMITHKLINE PLC For: Dec 02
GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Relvar� Ellipta� (fluticasone furoate / vilanterol 100/25 mcg) for the relief of various ...
GlaxoSmithKline Files EU Regulatory Submission For COPD Trea  London South East (registration) (blog)
GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD  Nasdaq
Beaufort Securities Breakfast Alert: Amryt Pharmaceuticals, Berkeley Group ...
"Ciao Matteo! Does Italy's decisive 'No' vote against Prime Minister Renzi's constitutional reform mean that European populists have now picked up the revolutionary baton?
GSK Stock: GlaxoSmithKline PLC Is a High-Dividend Stock
One sector that is known for large gross margins is the healthcare sector. Typically, high-gross-margin businesses are not looked at by dividend investors, the reason being that there is often no dividend.
GlaxoSmithKline PLC (LON:GSK) Issued With 'Buy' Rating At Jefferies ...  UK Market News
GlaxoSmithKline PLC (LON:GSK) Receives 'Buy' Rating From Brokers At ...  UK Market News
OTC News: Look Closer At GLAXOSMITHKLINE PLC (GLAXF)
GLAXOSMITHKLINE PLC (GLAXF)'s shares are generating intense interest from OTC investors after the price of the stock changed 0.21, reaching a price level of $18.72 following some recent trading.
How GlaxoSmithKline plc's first-mover advantage could power future profits
Today, eighteen months earlier than planned, GlaxoSmithKline(LSE: GSK) announced the filing of a regulatory submission with the US Food and Drug Administration for the firm's new three-in-one lung drug.
GlaxoSmithKline PLC files closed triple therapy for COPD in US  DirectorsTalk Interviews
GlaxoSmithKline and Innoviva celebrate early FDA submission of COPD treatment  Proactive Investors UK